China’s Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics: https://t.co/UWX4pCbmuT
— The Propell Group (@ThePropellGroup) October 2, 2017
#healthtech
China’s Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics: https://t.co/UWX4pCbmuT
— The Propell Group (@ThePropellGroup) October 2, 2017
#healthtech